Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 3KEH | P04062 | Crystal Structure of N370S Glucocerebrosidase mutant at pH 7.4 | |
| 3RIK | P04062 | The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease | Glucosylceramidase (E.C.3.2.1.45) |
| 3RIL | P04062 | The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease | Glucosylceramidase (E.C.3.2.1.45) |
| 5LVX | P04062 | Crystal structure of glucocerebrosidase with an inhibitory quinazoline modulator | Glucosylceramidase (E.C.3.2.1.45) |
| 7NWV | P04062 | Structure of recombinant human beta-glucocerebrosidase in complex with BODIPY Tagged Cyclophellitol activity based probe | |
| 8P3E | P04062 | Crystal structure of glucocerebrosidase in complex with allosteric activator | |
| 8P41 | P04062 | Crystal structure of glucocerebrosidase in complex with allosteric activator | |
| 8AWK | P04062 | Structure of recombinant human beta-glucocerebrosidase in complex with D-carbaxylosyl chloride | |
| 8AWR | P04062 | Structure of recombinant human beta-glucocerebrosidase in complex with L-carbaxylosyl chloride | |
| 8AX3 | P04062 | Structure of recombinant human beta-glucocerebrosidase in complex with L-carbaxylosyl fluoride | |
| 9F9Z | P04062 | Gcase in complex with small molecule inhibitor 1 | |
| 9FA3 | P04062 | Gcase in complex with small molecule inhibitor 1 | |
| 9FA6 | P04062 | Gcase in complex with small molecule inhibitor 1 | |
| 9FAD | P04062 | Gcase in complex with small molecule inhibitor 1 | |
| 9FAL | P04062 | Gcase in complex with small molecule inhibitor 1 | |
| 9FAY | P04062 | Gcase in complex with small molecule inhibitor 1 | |
| 9FAZ | P04062 | Gcase in complex with small molecule inhibitor 1 | |
| 9FB2 | P04062 | Gcase in complex with small molecule inhibitor 1 | |
| 9FDI | P04062 | Gcase in complex with small molecule inhibitor 1 | |
| 6EWK | P04058 | T. californica AChE in complex with a 3-hydroxy-2-pyridine aldoxime. | Acetylcholinesterase (E.C.3.1.1.7) |
| 6H14 | P04058 | Crystal structure of TcACHE complexed to 1-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)pyridin-2-yl)urea | |
| 6FQN | P04058 | Carbamylated T. californica acetylcholineterase bound to uncharged hybrid reactivator 2 | Acetylcholinesterase (E.C.3.1.1.7) |
| 6H12 | P04058 | Crystal structure of TcACHE complexed to 1-(6-Oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(((1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)methyl)pyridin-2-yl)urea | |
| 7B8E | P04058 | Torpedo californica acetylcholinesterase complexed with Ca+2 | |
| 7AIS | P04058 | Crystal structure of Torpedo Californica acetylcholinesterase in complex with 6-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]-N-(4-hydroxy-3-methoxybenzyl)hexanamide | |
| 6G4N | P04058 | Torpedo californica acetylcholinesterase bound to uncharged hybrid reactivator 2 | |
| 1CFJ | P04058 | METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH O-ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN) | |
| 6EZH | P04058 | Torpedo californica AChE in complex with indolic multi-target directed ligand | |
| 6G1W | P04058 | Crystal structure of Torpedo Californica acetylcholinesterase in complex with 2-{1-[2-(6-Chloro-1,2,3,4-tetrahydroacridin-9-ylamino)ethyl]-1H-1,2,3-triazol-4-yl}-N-[4-(hydroxy)-3-methoxybenzyl]acetamide | |
| 6G4M | P04058 | Torpedo californica acetylcholinesterase bound to uncharged hybrid reactivator 1 | |
| 6H13 | P04058 | Crystal structure of TcACHE complexed to1-(4-((Methyl((1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)pyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2,1-a]isoindol-10-yl)urea | |
| 6TT0 | P04058 | Crystal structure of a potent and reversible dual binding site Acetylcholinesterase chiral inhibitor | |
| 6FLD | P04058 | Carbamylated T. californica acetylcholineterase bound to uncharged hybrid reactivator 1 | Acetylcholinesterase (E.C.3.1.1.7) |
| 6EUC | P04058 | Reactivating oxime bound to Tc AChE's catalytic gorge. | Acetylcholinesterase (E.C.3.1.1.7) |
| 6EUE | P04058 | Rivastigmine analogue bound to Tc ACHE. | Acetylcholinesterase (E.C.3.1.1.7) |
| 6EZG | P04058 | Torpedo californica AChE in complex with indolic multi-target directed ligand | Acetylcholinesterase (E.C.3.1.1.7) |
| 6G1V | P04058 | Crystal structure of Torpedo Californica acetylcholinesterase in complex with 12-Amino-3-chloro-6,7,10,11-tetrahydro-5,9-dimethyl-7,11-methanocycloocta[b]quinolin-5-ium | |
| 7B38 | P04058 | Torpedo californica acetylcholinesterase complexed with Mg+2 | |
| 6G17 | P04058 | Non-aged form of Torpedo californica acetylcholinesterase inhibited by nerve agent tabun | |
| 6G1U | P04058 | Crystal structure of Torpedo Californica acetylcholinesterase in complex with 9-Amino-6-chloro-1,2,3,4-tetrahydro-10-methylacridin-10-ium | |
| 6G4O | P04058 | Non-aged form of Torpedo californica acetylcholinesterase inhibited by tabun analog NEDPA bound to uncharged reactivator 1 | |
| 6G4P | P04058 | Non-aged form of Torpedo californica acetylcholinesterase inhibited by tabun analog NEDPA bound to uncharged reactivator 2 | |
| 7AIU | P04058 | Crystal structure of Torpedo Californica acetylcholinesterase in complex with 8-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[b]quinolin-12-yl)amino]-N-(4-hydroxy-3-methoxybenzyl)octanamide | |
| 1DX6 | P04058 | STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-GALANTHAMINE AT 2.3A RESOLUTION | ACETYLCHOLINESTERASE (E.C.3.1.1.7) |
| 1E3Q | P04058 | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH BW284C51 | |
| 1E66 | P04058 | STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-HUPRINE X AT 2.1A RESOLUTION | |
| 1EA5 | P04058 | NATIVE ACETYLCHOLINESTERASE (E.C. 3.1.1.7) FROM TORPEDO CALIFORNICA at 1.8A resolution | |
| 1EVE | P04058 | THREE DIMENSIONAL STRUCTURE OF THE ANTI-ALZHEIMER DRUG, E2020 (ARICEPT), COMPLEXED WITH ITS TARGET ACETYLCHOLINESTERASE | |
| 1FSS | P04058 | ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH FASCICULIN-II | ACETYLCHOLINESTERASE, FASCICULIN II |
| 1GPK | P04058 | Structure of Acetylcholinesterase Complex with (+)-Huperzine A at 2.1A Resolution |
